Walder Wyss advised ANYbotics AG on CHF 45m Series B Round. ANYbotics, a leading maker of four-legged robots, closed its CHF 45 million series B financing round....
You must be a Standard 1 Year member to access this content.
Walder Wyss acted as legal counsel to the Mora group. Mora Group has completed the acquisition of Manuplast SA. Mora Group is specialized in the production...
You must be a Standard 1 Year member to access this content.
Walder Wyss has taken on the role of the official data protection advisor for Swisstransplant. The foundation Swisstransplant promotes, develops, and coordinates the nationwide transplantation of...
You must be a Standard 1 Year member to access this content.
Walder Wyss AG acted as Swiss legal advisor for Semperit. The listed Austrian Semperit Aktiengesellschaft Holding acquires RICO Group GmbH from its founders. The RICO Group...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised UBS Switzerland AG in the operation. UBS Switzerland AG operate as sole mandated lead arranger, sole bookrunner, agent and lender, with a syndicate of...
You must be a Standard 1 Year member to access this content.
Walder Wyss and HEUSSEN Rechtsanwaltsgesellschaft mbH advised Terra Quantum AG on the deal. Terra Quantum AG announced the onboarding of Investcorp as its newest investor. Quantum has...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised Distalmotion in connection with the transaction. Distalmotion SA successfully closed the first tranche of its $150 million Series F financing round led by...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised ITS Kanal Services Ltd on the deal. ITS Kanal Services Ltd acquired Künzli Group. Künzli Group is active in the areas of wastewater...
You must be a Standard 1 Year member to access this content.
Walder Wyss advises Alentis Therapeutics on the financing. Alentis Therapeutics has announced $105 million in Series C financing. The funding round was led by Jeito Capital...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised ImmunoGen, while Walder Wyss advised the funds managed by Pharmakon Advisors. ImmunoGen, Inc. (Nasdaq: IMGN) announced it has entered into a term loan...
You must be a Standard 1 Year member to access this content.
Walder Wyss advised collana IT on the transaction. collana IT GmbH has acquired PENTAG Informatik AG, a Swiss IT service provider based in Ittingen (Bern). PENTAG...
You must be a Standard 1 Year member to access this content.
Walder Wyss has advised the Avoras in this transaction. As part of its growth strategy, PwC Switzerland acquires Avoras, an established SAP-based business transformation consultant in...
You must be a Standard 1 Year member to access this content.
